Mark A. McKinlay

4.2k total citations · 1 hit paper
47 papers, 2.9k citations indexed

About

Mark A. McKinlay is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark A. McKinlay has authored 47 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Epidemiology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark A. McKinlay's work include Viral Infections and Immunology Research (15 papers), Cell death mechanisms and regulation (11 papers) and Respiratory viral infections research (10 papers). Mark A. McKinlay is often cited by papers focused on Viral Infections and Immunology Research (15 papers), Cell death mechanisms and regulation (11 papers) and Respiratory viral infections research (10 papers). Mark A. McKinlay collaborates with scholars based in United States, Australia and Switzerland. Mark A. McKinlay's co-authors include Srinivas K. Chunduru, Stephen M. Condon, John Silke, Guy D. Diana, Christopher A. Benetatos, David L. Vaux, Michael G. Rossmann, James E. Vince, W. Wei‐Lynn Wong and Diep Chau and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Mark A. McKinlay

47 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

2007 879 citations James E. Vince, W. Wei‐Lynn Wong et al. Cell profile →

Peers

Mark A. McKinlay

MB

EPIDE

CCM

IMMUN

ID

Qibin Leng China

MinKyung Yi United States

Timothy L. Tellinghuisen United States

Sun Hur United States

Ping Zhao China

Johnson Y. N. Lau United States

Soon B. Hwang South Korea

Makoto Hijikata Japan

Weidong Zhong United States

Kathie‐Anne Walters United States

Qibin Leng China

Mark A. McKinlay

766 ×0.5

MB

388 ×0.4

EPIDE

345 ×0.4

CCM

989 ×1.3

IMMUN

534 ×1.0

ID

Citations per year, relative to Mark A. McKinlay Mark A. McKinlay (= 1×) peers Qibin Leng

Countries citing papers authored by Mark A. McKinlay

Since Specialization

Citations

This map shows the geographic impact of Mark A. McKinlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. McKinlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. McKinlay more than expected).

Fields of papers citing papers by Mark A. McKinlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. McKinlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. McKinlay. The network helps show where Mark A. McKinlay may publish in the future.

Co-authorship network of co-authors of Mark A. McKinlay

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. McKinlay. A scholar is included among the top collaborators of Mark A. McKinlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. McKinlay. Mark A. McKinlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bresee, Joseph, Mark A. McKinlay, Jon S. Abramson, Keith P. Klugman, & Niteen Wairagkar. (2018). Global Funders Consortium for Universal Influenza Vaccine Development. Vaccine. 37(2). 211–213. 4 indexed citations

2.

Shaghaghi, Mohammadreza, Saeed Soleymanjahi, Hassan Abolhassani, et al.. (2018). New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine. 36(13). 1711–1719. 31 indexed citations

3.

Tanzer, Maria C., Nufail Khan, James Rickard, et al.. (2017). Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death and Differentiation. 24(3). 481–491. 38 indexed citations

4.

Hinman, Alan R. & Mark A. McKinlay. (2015). Immunization equity. Vaccine. 33. D72–D77. 12 indexed citations

5.

Krepler, Clemens, Srinivas K. Chunduru, Molly B. Halloran, et al.. (2013). The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells. Clinical Cancer Research. 19(7). 1784–1794. 79 indexed citations

6.

Feltham, Rebecca, Rhesa Budhidarmo, Peter D. Mace, et al.. (2011). Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization. Journal of Biological Chemistry. 286(19). 17015–17028. 120 indexed citations

7.

Vince, James E., Diep Chau, Bernard A. Callus, et al.. (2008). TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα. The Journal of Cell Biology. 182(1). 171–184. 209 indexed citations

8.

Vince, James E., W. Wei‐Lynn Wong, Nufail Khan, et al.. (2007). IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis. Cell. 131(4). 682–693. 879 indexed citations breakdown →

9.

Rotbart, Harley A., Juliette O’Connell, & Mark A. McKinlay. (1998). Treatment of human enterovirus infections. Antiviral Research. 38(1). 1–14. 41 indexed citations

10.

Rotbart, Harley A., P J Brennan, Kenneth H. Fife, et al.. (1998). Enterovirus Meningitis in Adults. Clinical Infectious Diseases. 27(4). 896–898. 58 indexed citations

11.

Kimberlin, David W., Stephen E. Straus, Karen K. Biron, et al.. (1995). Antiviral resistance in clinical practice. Antiviral Research. 26(4). 423–438. 22 indexed citations

12.

Kimberlin, David W., Donald M. Coen, Karen K. Biron, et al.. (1995). Molecular mechanisms of antiviral resistance. Antiviral Research. 26(4). 369–401. 54 indexed citations

13.

Kremer, Marcia J., Michael G. Rossmann, Guy D. Diana, et al.. (1994). Human Rhinovirus 14 Complexed with Fragments of Active Antiviral Compounds. Virology. 202(1). 360–369. 16 indexed citations

14.

Willingmann, Peter, Marcia J. Kremer, Michael S. Chapman, et al.. (1993). A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A. Journal of Molecular Biology. 230(1). 206–226. 66 indexed citations

15.

Oliveira, Marcos Antônio de, Rui Zhao, Wai-Ming Lee, et al.. (1993). The structure of human rhinovirus 16. Structure. 1(1). 51–68. 131 indexed citations

16.

Diana, Guy D., et al.. (1989). Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus. Journal of Medicinal Chemistry. 32(2). 450–455. 38 indexed citations

17.

Kim, Sangsoo, Thomas J. Smith, Michael S. Chapman, et al.. (1989). Crystal structure of human rhinovirus serotype 1A (HRV1A). Journal of Molecular Biology. 210(1). 91–111. 161 indexed citations

18.

Badger, John, Sriram Krishnaswamy, Marcia J. Kremer, et al.. (1989). Three-dimensional structures of drug-resistant mutants of human rhinovirus 14. Journal of Molecular Biology. 207(1). 163–174. 26 indexed citations

19.

Diana, Guy D., Michaël Otto, Adi M. Treasurywala, et al.. (1988). Enantiomeric effects of homologs of disoxaril on the inhibitory activity against human rhinovirus-14. Journal of Medicinal Chemistry. 31(3). 540–544. 15 indexed citations

20.

Diana, Guy D., Michaël Otto, & Mark A. McKinlay. (1985). Inhibitors of picornavirus uncoating as antiviral agents. Pharmacology & Therapeutics. 29(3). 287–297. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact